Partial failure of CPAP treatment for sleep apnoea: Analysis of the French national sleep database

Respirology ◽  
2019 ◽  
Vol 25 (1) ◽  
pp. 104-111 ◽  
Author(s):  
Sébastien Bailly ◽  
Najeh Daabek ◽  
Ingrid Jullian‐Desayes ◽  
Marie Joyeux‐Faure ◽  
Marc Sapène ◽  
...  
Keyword(s):  
Sleep Apnoea ◽  
Partial Failure ◽  
Cpap Treatment

scholarly journals Two months follow up of auto-CPAP treatment in patients with obstructive sleep apnoea

Thorax ◽  
1999 ◽  
Vol 54 (2) ◽  
pp. 147-149 ◽  
Author(s):  
A Boudewyns ◽  
V Grillier-Lanoir ◽  
M J Willemen ◽  
W A De Cock ◽  
P H Van de Heyning ◽  
...  
Keyword(s):  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Cpap Treatment ◽  
Obstructive Sleep

Auditory evoked potentials remain abnormal after CPAP treatment in patients with severe obstructive sleep apnoea

2012 ◽  
Vol 123 (2) ◽  
pp. 310-317 ◽  
Author(s):  
Andrew Vakulin ◽  
Peter G. Catcheside ◽  
Stuart D. Baulk ◽  
Nick A. Antic ◽  
Cameron J. van den Heuvel ◽  
...  
Keyword(s):  
Evoked Potentials ◽  
Obstructive Sleep Apnoea ◽  
Auditory Evoked Potentials ◽  
Sleep Apnoea ◽  
Cpap Treatment ◽  
Obstructive Sleep

Performance assessment of a medical device for home monitoring of CPAP treatment in patients with obstructive sleep apnoea syndrome

2013 ◽  
Vol 14 ◽  
pp. e113-e114
Author(s):  
M. Elbaz ◽  
T. Joelle ◽  
C. Amelie ◽  
P. Benoit ◽  
W. Claude ◽  
...  
Keyword(s):  
Performance Assessment ◽  
Medical Device ◽  
Obstructive Sleep Apnoea ◽  
Home Monitoring ◽  
Sleep Apnoea ◽  
Obstructive Sleep Apnoea Syndrome ◽  
Sleep Apnoea Syndrome ◽  
Cpap Treatment ◽  
Obstructive Sleep

scholarly journals Continuous positive airway pressure treatment for obstructive sleep apnoea: Maori, Pacific and New Zealand European experiences

2014 ◽  
Vol 6 (3) ◽  
pp. 221 ◽  
Author(s):  
Jessie Bakker ◽  
Karyn O’Keeffe ◽  
Alister Neill ◽  
Angela Campbell
Keyword(s):  
New Zealand ◽  
Continuous Positive Airway Pressure ◽  
Obstructive Sleep Apnoea ◽  
Role Models ◽  
Airway Pressure ◽  
Positive Airway Pressure ◽  
Sleep Apnoea ◽  
Cpap Adherence ◽  
Cpap Treatment ◽  
Obstructive Sleep

INTRODUCTION: Continuous positive airway pressure (CPAP) is an effective treatment of obstructive sleep apnoea (OSA), but can be limited by poor adherence. In New Zealand (NZ), ethnicity has been shown to be a predictor of CPAP adherence. This study aimed to explore Maori, Pacific and NZ European patients’ experience of CPAP treatment. METHODS: Patients identifying as Maori, Pacific, or NZ European ethnicity referred for CPAP treatment for OSA attended separate, 1.5-hour group discussions facilitated by a health care worker of the same ethnic group, using an interview template. Thematic analysis was applied to the discussion transcripts independently by two investigators, following published guidelines. FINDINGS: Five Maori, five Pacific, and eight NZ Europeans participated (mean age 47, range 30–71 years, mean ± standard deviation CPAP adherence 6.32 ±1.25 hours/night). Patients in all three groups reported that they had little knowledge of OSA or CPAP prior to treatment initiation. All groups identified barriers to treatment (both at the CPAP initiation phase and long term), reported feelings of being ‘overwhelmed’ with information during the initial CPAP education session, and discussed the importance of successful role models. Family and friends were generally reported as being supportive of CPAP therapy. CONCLUSION: The three groups all reported similar initial CPAP experiences, highlighting access barriers to publicly funded assessment and treatment pathways, and sleep health knowledge as key issues. Educational resources to improve access, enable self-management, and increase community awareness of OSA would help overcome some of the issues identified in this study. KEYWORDS: Continuous positive airway pressure; obstructive sleep apnea; ethnic groups; focus groups

scholarly journals Resistant/Refractory Hypertension and Sleep Apnoea: Current Knowledge and Future Challenges

2019 ◽  
Vol 8 (11) ◽  
pp. 1872 ◽  
Author(s):  
Grace Oscullo ◽  
Gerard Torres ◽  
Francisco Campos-Rodriguez ◽  
Tomás Posadas ◽  
Angela Reina-González ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Cardiovascular Risk ◽  
Current Knowledge ◽  
Reduce Blood Pressure ◽  
Sleep Apnoea ◽  
Refractory Hypertension ◽  
Hypertensive Patients ◽  
Cpap Treatment ◽  
Obstructive Sleep ◽  
Clinically Significant

Hypertension is one of the most frequent cardiovascular risk factors. The population of hypertensive patients includes some phenotypes whose blood pressure levels are particularly difficult to control, thus putting them at greater cardiovascular risk. This is especially true of so-called resistant hypertension (RH) and refractory hypertension (RfH). Recent findings suggest that the former may be due to an alteration in the renin–angiotensin–aldosterone axis, while the latter seems to be more closely related to sympathetic hyper-activation. Both these pathophysiological mechanisms are also activated in patients with obstructive sleep apnoea (OSA). It is not surprising, therefore, that the prevalence of OSA in RH and RfH patients is very high (as reflected in several studies) and that treatment with continuous positive airway pressure (CPAP) manages to reduce blood pressure levels in a clinically significant way in both these groups of hypertensive patients. It is therefore necessary to incorporate into the multidimensional treatment of patients with RH and RfH (changes in lifestyle, control of obesity and drug treatment) a study of the possible existence of OSA, as this is a potentially treatable disease. There are many questions that remain to be answered, especially regarding the ideal combination of treatment in patients with RH/RfH and OSA (drugs, renal denervation, CPAP treatment) and patients’ varying response to CPAP treatment.

CPAP treatment of obstructive sleep apnoea and neurodevelopmental deficits

1995 ◽  
Vol 84 (7) ◽  
pp. 791-794 ◽  
Author(s):  
E Tirosh ◽  
Y Tal ◽  
M Jaffe
Keyword(s):  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Cpap Treatment ◽  
Obstructive Sleep ◽  
Neurodevelopmental Deficits
Sign in / Sign up

Export Citation Format

Share Document